OmniActive Health Technologies
Indian supplier of branded curcumin and lutein ingredients and a nutrient-delivery technology.
- MOQ
- Not publicly disclosed
- LEAD TIME
- Not publicly disclosed
Overview
OmniActive Health Technologies is an India-based specialty and botanical-actives ingredient supplier with branded ingredients including CurcuWIN (curcumin), Lutemax 2020 and Lutemax Free Lutein (carotenoids), and UltraSOL nutrient-delivery technology. Active M&A signal as of Q1 2026: Swedish private equity firm EQT is the sole bidder following rejection of a competing Temasek/Novo Holdings offer; valuation gap reported (~$1B hoped vs lower bids). The M&A signal reflects a healthy operating company exploring exit.
Certifications
0 of 1 certification independently confirmed. What this means
Capabilities
- PRODUCT TYPES
- CurcuWIN (curcumin) · Lutemax 2020 + Lutemax Free Lutein (carotenoids) · UltraSOL nutrient-delivery technology · Specialty and botanical actives
- CAPABILITIES
- Botanical extracts or ingredients · Branded or patented ingredients · Carotenoids · Delivery or absorption technology
Sources
- OmniActive CurcuWIN product page(2026-05-26)
- Whalesbook 2026 EQT-OmniActive M&A coverage(2026-05-26)
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Current FDA GRAS Notice Inventory entries (if any) for Lutemax 2020 and CurcuWIN
- EQT acquisition close-or-collapse status
- ENovate Biolife portfolio integration scope
- Active M&A negotiations with EQT as of Q1 2026 — entity ownership may change post-deal-close; refresh entity status after Q3 2026 or upon deal closure (per Whalesbook 2026 reporting)
- GRAS status for CurcuWIN and Lutemax 2020 rests on trade-press reports; the underlying GRAS documentation for either was not reviewed
- OmniActive recently acquired ENovate Biolife (per PR Newswire); ingredient portfolio scope may expand or shift
- Certification directory checks for OmniActive were not completed
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
The connection map between OmniActive Health Technologies and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Our Evaluation Method
A full assessment applies six checks. Source-Checked listings get a lighter review.
- Independent confirmation: Claims backed by documentation, not marketing copy
- How recent the data is: Information reviewed and dated within the last 12 months
- Sources we traced: Sources cited for every key claim
- Inconsistencies flagged: Where a company's claims and public records disagree, we say so
- What we disclose: Material connections stated directly on affected listings
- What we don't know: When we can't assess something, we say so explicitly
Interested in OmniActive Health Technologies?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.